Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T2DL
|
|||
| Former ID |
DIB002159
|
|||
| Drug Name |
GM-7050
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Terminated | [1] | |
| Company |
Glycomed Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell adhesion molecule (CADM) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005329) | |||
| REF 2 | US patent application no. 6,673,908, Tumor necrosis factor receptor 2. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.